Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2 - Test2 - elhamkhani - TriplyDB

Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2

Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2

http://www.wikidata.org/entity/Q22001444

about

Teduglutide, a novel glucagon-like peptide 2 analog, in the treatment of patients with short bowel syndrome Gastrointestinal hormones regulating appetite Conformational and molecular interaction studies of glucagon-like peptide-2 with its N-terminal extracellular receptor domain The Pathogenesis of Resection-Associated Intestinal Adaptation Structure-function of the glucagon receptor family of G protein-coupled receptors: the glucagon, GIP, GLP-1, and GLP-2 receptors Glucagon-like peptide 2 decreases mortality and reduces the severity of indomethacin-induced murine enteritis Glucagon-like peptide (GLP)-2 action in the murine central nervous system is enhanced by elimination of GLP-1 receptor signaling Identification and analysis of the β-catenin1 gene in half-smooth tongue sole (Cynoglossus semilaevis)Interdependency of EGF and GLP-2 Signaling in Attenuating Mucosal Atrophy in a Mouse Model of Parenteral Nutrition GLP-2 potentiates L-type Ca2+ channel activity associated with stimulated glucose uptake in hippocampal neurons.Intestinal growth factors: potential use in the treatment of inflammatory bowel disease and their role in mucosal healing.Lessons from genetically engineered animal models. VII. Apoptosis in intestinal epithelium: lessons from transgenic and knockout mice.Stem cells: the intestinal stem cell as a paradigm.Gut hormones, and short bowel syndrome: the enigmatic role of glucagon-like peptide-2 in the regulation of intestinal adaptation.Modulation of specific intestinal epithelial progenitors by enteric neurons.Research resource: Gene profiling of G protein-coupled receptors in the arcuate nucleus of the female.Hormonal regulation of physiological cell turnover and apoptosis.The CNS glucagon-like peptide-2 receptor in the control of energy balance and glucose homeostasis Therapeutic potential of the intestinotropic hormone, glucagon-like peptide-2.The glucagon-like peptide-2 receptor C terminus modulates beta-arrestin-2 association but is dispensable for ligand-induced desensitization, endocytosis, and G-protein-dependent effector activation.Proglucagon-derived peptides: mechanisms of action and therapeutic potential.Gut adaptation and the glucagon-like peptides Genetic variants modulating CRIPTO serum levels identified by genome-wide association study in Cilento isolates Glucagon-like peptide 2 (GLP-2) accelerates the growth of colonic neoplasms in mice.Glucagon-like peptide-2-stimulated protein synthesis through the PI 3-kinase-dependent Akt-mTOR signaling pathway.Intestinotrophic glucagon-like peptide-2 (GLP-2) activates intestinal gene expression and growth factor-dependent pathways independent of the vasoactive intestinal peptide gene in mice Mechanism of action of glucagon-like peptide-2 to increase IGF-I mRNA in intestinal subepithelial fibroblasts Irinotecan-induced mucositis: the interactions and potential role of GLP-2 analogues.Class II G protein-coupled receptors and their ligands in neuronal function and protection GLP-2 receptor in POMC neurons suppresses feeding behavior and gastric motility.Teduglutide for the treatment of short bowel syndrome.Biologic actions and therapeutic potential of the proglucagon-derived peptides.Disruption of the murine Glp2r impairs Paneth cell function and increases susceptibility to small bowel enteritis Glucagon-like peptide-2 does not modify the growth or survival of murine or human intestinal tumor cells.Lipid raft-dependent glucagon-like peptide-2 receptor trafficking occurs independently of agonist-induced desensitization.Early but not late administration of glucagon-like peptide-2 following ileo-cecal resection augments putative intestinal stem cell expansion.Enteral nutrients potentiate the intestinotrophic action of glucagon-like peptide-2 in association with increased insulin-like growth factor-I responses in rats.GLP-1 receptor signaling is not required for reduced body weight after RYGB in rodents.Growth factors: possible roles for clinical management of the short bowel syndrome.The therapeutic potential of targeting the glucagon-like peptide-2 receptor in gastrointestinal disease.

P2860

70d4e8a5b44197821dde64a3905604f38908b449 b4d9f178f76f3a1d85d5aa16e5b6fe3e0779d423

P248

Q24629712-BF5382E1-F83A-414B-BACA-535351C036C1 Q24669951-6B737E5C-CF1E-4E29-9DAB-EC9103807E34 Q27666380-9311A246-D95B-4028-BA5E-469FF88BF482 Q28076127-0559DBA2-D426-4873-9A9B-6C4B27A58E6A Q28203273-44021923-B6E3-43CF-8637-592794175D4C Q28376612-475B22E6-39A8-4D67-A62E-23B79A0C93EE Q28581928-66530C6C-DC23-40A5-A8C3-C8C24C525D02 Q30377025-EE19124D-F704-4C8A-93ED-613AC11F6709 Q33600424-0EE90E4D-1E8E-4008-B386-EB57D1752729 Q33655510-463F52AD-CD72-4E38-B791-222C08EC6ECC Q33694525-2644B91E-4A96-442D-965D-24274691C067 Q33822567-0B033E7A-D5BE-4220-A257-4A5F36DD8F54 Q33846215-142857E7-CB76-4A32-B2C2-B0F0D8A77DD5 Q33865971-23F5C2B5-F577-448C-AE12-6F38463C9640 Q33947818-F9AB16BE-4C37-43DA-9747-08EA1B51775A Q33977447-231A7348-45B8-4700-BEFB-780C79B4A345 Q33992348-E7E70FA2-32E6-4794-BE62-3ABC473A713D Q34201215-492A3202-F4A4-4471-BC80-FED1C12487A1 Q34281175-1F848D0A-5EEF-45F6-9798-4199A62F0069 Q34409674-D9D5AE12-A1F1-4116-B193-231D7094AB3F Q34452524-1FE7AFEA-147A-4AAB-AE74-A76D3318A3A9 Q34526042-16912BB0-8D20-42A8-B099-7410F06C702E Q35023500-C29837CB-3803-48F0-95EA-C0AB6D77E3BC Q35596753-E5F47C80-5548-416B-B8D2-07CC41146566 Q35756432-D34C67F6-431F-479F-965C-369B9E41AC91 Q35986076-42D68AE3-7F2C-42B4-81ED-5A294929ABB4 Q36063090-BE57D362-EEE9-48C6-B1AB-CA06EF4442DF Q36171894-F15AFAB3-14A8-4B73-B1CD-ABE855040980 Q36211439-00BC74E6-1339-4A30-87F2-7EC97552D69A Q36312440-622B66FA-CC62-47EC-9355-9479D852A89F Q36480664-FD6DE6F5-58B5-42AE-8AE2-8E0AC9158A9C Q36575421-7049CD1D-DEDF-4DA6-AF7B-F1D0B19742BB Q36710034-9961EC47-9BF6-4160-A2F4-660CE14644DC Q36710038-890CBBE4-9F28-4CC7-A19E-943A4C8BDACA Q37031716-234619C7-7C60-45D6-9A46-640CD37232DB Q37138788-091613F3-66DB-4E84-A4B5-AB89F8828B72 Q37200132-A0ED5776-B5FC-4264-A992-0BD24243CCA4 Q37629291-6607F64B-EEF9-4000-ABD3-EBFE84F82815 Q37685500-4B102197-8816-4EAF-98F6-DCEC3D6FD726 Q37840099-947D7873-3907-4EB1-BCD5-D4B9CB2C6145

P2860

Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2

http://www.wikidata.org/entity/Q22001444

description

1999 nî lūn-bûn

@nan

1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Prototypic G protein-coupled r ...... factor glucagon-like peptide 2

@ast

Prototypic G protein-coupled r ...... factor glucagon-like peptide 2

@en

Prototypic G protein-coupled r ...... factor glucagon-like peptide 2

@en-gb

Prototypic G protein-coupled r ...... factor glucagon-like peptide 2

@nl

type

label

Prototypic G protein-coupled r ...... factor glucagon-like peptide 2

@ast

Prototypic G protein-coupled r ...... factor glucagon-like peptide 2

@en

Prototypic G protein-coupled r ...... factor glucagon-like peptide 2

@en-gb

Prototypic G protein-coupled r ...... factor glucagon-like peptide 2

@nl

prefLabel

Prototypic G protein-coupled r ...... factor glucagon-like peptide 2

@ast

Prototypic G protein-coupled r ...... factor glucagon-like peptide 2

@en

Prototypic G protein-coupled r ...... factor glucagon-like peptide 2

@en-gb

Prototypic G protein-coupled r ...... factor glucagon-like peptide 2

@nl

P1433

Q22001444-49AC3ED1-82F1-4086-8A8F-C6D2FF4BD4DE

P1476

Q22001444-E33C05C8-E72C-4BC3-AF2D-078CEA1CD258

P2093

Q22001444-2E9BAB58-3174-4FC4-8C7B-028985379216

Q22001444-33F4EAA0-7C14-4915-9EAA-845B43A3647B

Q22001444-45369DA2-ECFA-495B-8266-24D9AFCFA5A7

Q22001444-5492A799-AD39-4FBE-BBAC-C16030159BE0

Q22001444-7CA92349-499F-4CBB-8CF3-F5B7CCC8A35F

Q22001444-7FECD4E9-5E83-4939-9BCF-98BCFEDEB399

Q22001444-86207670-75BC-4A74-B431-30FBE22B9E34

Q22001444-86F5217A-989E-4D55-9E8D-821F482D6875

Q22001444-8DE9873E-8256-4531-BD28-03C55FC027A1

Q22001444-C6B6B1E6-2C5D-436B-BDF5-D4D4612C6AF5

P2860

Q22001444-0D1576D0-B2C4-4CE2-BA4F-F23FC24CB16F

Q22001444-0FB5E90E-7A32-4FEC-A560-127BDCDE280C

Q22001444-5C692C5F-EC50-465F-9627-709DC2DEC066

Q22001444-70766E66-B2DB-4C97-8742-B8D4C3465A8C

Q22001444-74307C07-4DAC-414A-8689-2641ECD86CC7

Q22001444-7AEDAF18-10CE-49F0-B5B8-DE550E6A2BD2

Q22001444-A02640C6-3A50-46EE-B949-8061523605E8

Q22001444-B7E68E65-032C-4F11-91EC-748442AA3553

Q22001444-DF5AA3B2-FA32-4C40-A7F8-81D1294D2098

Q22001444-E1F53510-8124-44EA-A9E1-3A7FEBE1F06E

P304

Q22001444-B458174E-AC69-47F7-9CFF-54F56E598329

P31

Q22001444-05EDDF64-7373-4B9C-B2F9-ECC5070ACC3B

P356

Q22001444-744D4BB2-BB82-4D2C-B24C-77B5133FA447

P407

Q22001444-11002D31-2B7F-4AB7-B9E0-B256F0629617

P433

Q22001444-D7C2CA28-C3FF-4D56-BF3B-ECC0ACABE6AA

P478

Q22001444-5ED8AFA6-7FB2-4C63-9A1F-EE4ADF564D78

P577

Q22001444-2340BCFE-95F5-4CBF-9256-36F7F668931F

P5875

Q22001444-569A7A55-214C-457F-92E7-76BBDC44BD36

P698

Q22001444-3E7EDF58-A6BF-41F0-8071-4657158B0365

P921

Q22001444-100B3DDE-8489-4680-9FF1-8802B4EF0314

Q22001444-3D82124B-3247-4B24-8A2C-54EE1156A2F6

Q22001444-8D73E80B-03DB-4732-AE85-1ABB5EFC06C0

Q22001444-F6334EE5-E8C2-44E8-8DCA-DCD5D18FEF9C

P932

Q22001444-C54E9644-B3D4-468D-96A9-66A99D9E15CF

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Prototypic G protein-coupled r ...... factor glucagon-like peptide 2

@en

P2093

A Crivici

http://www.w3.org/2001/XMLSchema#string

A K Gupta

http://www.w3.org/2001/XMLSchema#string

D G Munroe

http://www.w3.org/2001/XMLSchema#string

D J Drucker

http://www.w3.org/2001/XMLSchema#string

F Kooshesh

http://www.w3.org/2001/XMLSchema#string

G Rizkalla

http://www.w3.org/2001/XMLSchema#string

H Chen

http://www.w3.org/2001/XMLSchema#string

H Wang

http://www.w3.org/2001/XMLSchema#string

K McCallum

http://www.w3.org/2001/XMLSchema#string

L Demchyshyn

http://www.w3.org/2001/XMLSchema#string

P2860

Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1

Cloning and expression of a human glucagon receptor

Hamster gastric inhibitory polypeptide receptor expressed in pancreatic islets and clonal insulin-secreting cells: its structure and functional properties.

Induction of intestinal epithelial proliferation by glucagon-like peptide 2.

Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide.

Humoral regulation of intestinal adaptation.

Expression cloning and signaling properties of the rat glucagon receptor.

Biological actions of glucagon-like peptide(GLP)-2 revealed--how pluripotential is the glucagon gene?

Glucagon-like peptides.

Enteroglucagon cell hyperfunction in rat small intestine after gut resection.

P304

1569-73

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.96.4.1569

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

96

http://www.w3.org/2001/XMLSchema#string

P577

1999-02-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13299529

http://www.w3.org/2001/XMLSchema#string

P698

9990065

http://www.w3.org/2001/XMLSchema#string

P921

Glucagon like peptide 2 receptor

receptor binding

G protein-coupled receptor

P932

15520

http://www.w3.org/2001/XMLSchema#string